A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies
针对妇科恶性肿瘤的白蛋白紫杉醇/贝伐单抗(AB160)纳米免疫偶联物治疗 I 期临床试验
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-23-3196
Eleftheria Kalogera, Wendy K Nevala, Heidi D Finnes, Vera J Suman, Jill M Schimke, Carrie A Strand, Lisa A Kottschade, Rachel A Kudgus, Sarah A Buhrow, Laura R Becher, Liyi Geng, Gretchen E Glaser, Megan E Grudem, Aminah Jatoi, Carolyn M Klampe, Amanika Kumar, Carrie L Langstraat, Robert R McWilliam